Veeva price target raised to $300 from $285 at Barclays

Barclays raised the firm’s price target on Veeva (VEEV) to $300 from $285 and keeps an Overweight rating on the shares. The company reported better than expected Q1 billings of $714M, driven by outperformance in Crossix, the analyst tells investors in a research note. The firm says Veeva’s guidance is going up across the board, and there was no change in macro assumptions.